Showing results (311-320 of 354) with videos related to
Sort By:
Pageof 36
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2008
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP)Carmine Zoccali, Daniel Abramowicz, Jorge B Cannata-Andia, et al.Nature Reviews. Nephrology|April 25, 2017
The systemic nature of CKDCarmine Zoccali, Raymond Vanholder, Ziad A Massy, et al.Kidney International|August 3, 2020
Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney diseaseMathilde Luce, Christophe Barba, Dan Yi, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 18, 2019
Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis PatientsAdrian Slee, Clare McKeaveney, Gary Adamson, et al.Kidney International|December 2, 2021
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysisMaxime Espi, Xavier Charmetant, Thomas Barba, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2020
Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) studyClare McKeaveney, Adrian Slee, Gary Adamson, et al.Toxins|April 27, 2023
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney DiseaseCarolla El Chamieh, Islam Amine Larabi, Solène M Laville, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2019
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTAPantelis Sarafidis, Charles J Ferro, Enrique Morales, et al.Nature Reviews. Nephrology|June 13, 2020
Plant-based diets to manage the risks and complications of chronic kidney diseaseJuan J Carrero, Ailema González-Ortiz, Carla M Avesani, et al.Journal of Cellular Physiology|January 21, 2026
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney DiseaseNajwa Skafi, Solenne Pelletier, Christophe O Soulage, et al.Pageof 36